Estimates Revisions CStone Pharmaceuticals Deutsche Boerse AG
Stocks
PH4
KYG2588M1006
Pharmaceuticals
|
Market Closed -
Deutsche Boerse AG
11:55:01 11/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.6158 EUR | -5.87% |
|
-17.34% | +8.04% |
| 09-07 | CStone Pharmaceuticals Joins Stock Connect Southbound Trading | MT |
| 08-31 | Cstone Pharmaceuticals Provides Updates on Cs2009 and Pipeline 2.0 Clinical Trials and Product Portfolio | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
CStone Pharmaceuticals(2616)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
CStone Pharmaceuticals(2616)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
CStone Pharmaceuticals(2616)
EBIT
Dividend / Share (DPS)
Data source:
CStone Pharmaceuticals(2616)
Cash or Net Debt
- Stock Market
- Stocks
- 2616 Stock
- PH4 Stock
- Consensus CStone Pharmaceuticals
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
